Gonadotropin levels at the start of ovarian stimulation predict normal fertilization after hCG re-trigger in GnRH antagonist cycles

被引:0
|
作者
Kitasaka, Hiroya [1 ]
Tokoro, Mikiko [1 ,2 ]
Kojima, Masae [1 ]
Fukunaga, Noritaka [1 ,2 ]
Asada, Yoshimasa [1 ,2 ]
机构
[1] Asada Ladies Clin, Nagoya, Aichi, Japan
[2] Asada Inst Reprod Med, Kasugai, Aichi, Japan
关键词
controlled ovarian stimulation; gonadotropin‐ releasing hormone antagonist protocol; releasing hormone agonist trigger; luteinizing hormone surge; oocyte maturation; INTRACYTOPLASMIC SPERM INJECTION; ENDOTHELIAL GROWTH-FACTOR; HORMONE AGONIST TRIGGER; OOCYTE MATURATION; HYPERSTIMULATION SYNDROME; MENSTRUAL-CYCLE; CORPUS-LUTEUM; EXPRESSION; FAILURE; ICSI;
D O I
10.1002/rmb2.12359
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose To assess the appropriateness of human chorionic gonadotropin (hCG) re-trigger in poor responders to gonadotropin-releasing hormone agonist (GnRHa) trigger in controlled ovarian stimulation (COS) cycles. Methods The 2251 cycles in 2251 patients triggered with GnRHa for oocyte stimulation, with or without requiring hCG re-trigger between 2013 and 2018, were retrospectively analyzed to compare gonadotropin levels at the start of COS and the rate of normal fertilization between the re-trigger and non-re-trigger group. Furthermore, patients in the re-trigger group were stratified by the rate of normal fertilization (good: >= 60% or poor: <60%) to compare patient demographics, hormone profiles, and clinical outcome between the subgroups. Results In the re-trigger group, FSH and LH levels at the start of COS were significantly lower in the good fertilization group than in the poor fertilization group (P < .01). Receiver operating characteristic curves identified cutoff values of the FSH and LH levels of 1.30 and 0.35 mIU/mL, respectively, for predicting >= 60% normal fertilization. Conclusion Gonadotropin levels at the start of COS are predictors of response to GnRHa trigger and hCG re-trigger necessity, and may serve as indicators to help clinicians appropriately choose hCG re-trigger rather than abandoning the cycles or continuing the first oocyte aspiration attempt.
引用
收藏
页码:96 / 107
页数:12
相关论文
共 50 条
  • [41] Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment
    Beckers, NGM
    Macklon, NS
    Eijkemans, MJ
    Ludwig, M
    Felberbaum, RE
    Diedrich, K
    Bustion, S
    Loumaye, E
    Fauser, BCJM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09): : 4186 - 4192
  • [42] Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation:: Effect on hormonal levels and follicular development in in vitro fertilization cycles
    Kolibianakis, EM
    Albano, C
    Camus, M
    Tournaye, H
    Van Steirteghem, AC
    Devroey, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12): : 5632 - 5637
  • [43] An approach to controlled ovarian hyperstimulation (COH) in the setting of persistently elevated follicle stimulating hormone (FSH) levels: Administration of a gonadotropin releasing hormone antagonist (GnRH-an) prior to gonadotropin stimulation.
    Lipari, C. W.
    Kulp, J. L.
    Alexander, C. J.
    King, J. A.
    Kolp, L.
    Garcia, J.
    FERTILITY AND STERILITY, 2006, 86 : S438 - S439
  • [44] Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report
    Itskovitz-Eldor, J
    Kol, S
    Mannaerts, B
    HUMAN REPRODUCTION, 2000, 15 (09) : 1965 - 1968
  • [45] Low Serum LH Levels During Ovarian Stimulation With GnRH Antagonist Protocol Decrease the Live Birth Rate After Fresh Embryo Transfers but Have No Impact in Freeze-All Cycles
    Luo, Yiyang
    Liu, Shan
    Su, Hui
    Hua, Lin
    Ren, Haiying
    Liu, Minghui
    Wan, Yuting
    Li, Huanhuan
    Li, Yuan
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [46] COMPARISON OF ANTAGONIST TO AGONIST IN CONTROLLED OVARIAN STIMULATION (COS) CYCLES USING HUMAN-DERIVED GONADOTROPIN ON IN VITRO FERTILIZATION (IVF) OUTCOMES. A PROSPECTIVE RANDOMIZED CONTROLLED STUDY.
    Anderson, S. H.
    Pereira, N. E.
    Brasile, D. R.
    Orris, J. J.
    Davies, E. B.
    Glassner, M. J.
    FERTILITY AND STERILITY, 2014, 102 (03) : E224 - E224
  • [47] A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol
    Hohmann, FP
    Macklon, NS
    Fauser, BCJM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01): : 166 - 173
  • [48] Reproductive outcomes of normal ovarian reserve patients after progestin-primed ovarian stimulation with chlormadinone acetate vs GnRH antagonist: A retrospective study with inverse-probability-of-treatment weighting
    Handa, M.
    Takiuchi, T.
    Kawaguchi, S.
    Komukai, S.
    Kitamura, T.
    Miyake, T.
    Ohara, Y.
    Doshida, M.
    Takeuchi, T.
    Matsubayashi, H.
    Ishikawa, T.
    Kimura, T.
    HUMAN REPRODUCTION, 2022, 37
  • [49] A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol -: Response
    Fauser, BCJM
    Macklon, NS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09): : 4510 - 4511
  • [50] Gonadotropin-releasing hormone (GnRH) antagonist cycle comparing polycystic ovarian syndrome (PCO) versus normal female or tubal factor in women pretreated with oral contraceptives (OC) before in vitro fertilization.
    Giles, J
    Garcia-Velasco, JA
    Guillen, A
    Requena, A
    Remohi, J
    FERTILITY AND STERILITY, 2005, 84 : S313 - S314